Advertisement

Pharmacy

Attorneys general from 44 states are suing the nation's largest generic drugmakers, claiming they conspired to inflate prices of more than 100 generic drugs by as much as 1,000 percent, according to The New York Times.

Gilead Sciences has agreed to donate drugs to the federal government that reduce the risk of HIV transmission for up to 200,000 people a year, HHS Secretary Alex Azar announced May 9.  

Advertisement

Below are eight legal actions involving members of the drug supply chain, including pharmaceutical companies, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.

McKesson has renewed its distribution agreement with its largest client, CVS Health, the drug distributor announced during its earnings call May 9, according to Reuters.

A generic version of Gilead Sciences' HIV prevention drug, Truvada, will be available one year earlier than expected due to an agreement struck with Teva Pharmaceuticals a few years ago, the drugmaker announced May 8, according to CNBC.

Advertisement